NYMC > News and Events > NYMC in the News

Harrison research company Sapience Therapeutics receives second federal grant

June 22, 2021

BioIncSapience Therapeutics, a Harrison-based company that is involved in developing drugs to treat cancer, has been awarded a second Small Business Innovative Research grant from the federal government’s National Institute of Allergy and Infectious Diseases of the National Institutes of Health.

BioInc@NYMC news: Barry Kappel, Ph.D., M.B.A., president, chief executive officer and director of Sapience Therapeutics, a BioInc@NYMC client

Source: Westchester and Fairfield Country Business Journal